P

PKA

Europe, Hovedstaden, Denmark, Hellerup

Description

PKA is a company that provides pension funds for hospitals, elderly care, social services, and other areas.

Investor Profile

PKA has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Private Equity, Series A rounds (top funding stages).
  • Majority of deals are located in Denmark, Norway, United States.
  • Strong thematic focus on Biotechnology, Biopharma, Pharmaceutical.

Stage Focus

  • Series Unknown (43%)
  • Private Equity (29%)
  • Series A (14%)
  • Debt Financing (14%)

Country Focus

  • Denmark (57%)
  • Norway (14%)
  • United States (14%)
  • Chile (14%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Battery
  • Electrical Distribution
  • Electronics
  • Manufacturing
  • Health Care
  • Energy
  • Food And Beverage
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PKA frequently co-invest with?

Agder Energi Venture
Europe, Vest-Agder, Norway, Kristiansand
Co-Investments: 1
ABB
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
EIR Ventures
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
N
Europe, Vestfold, Norway, Holmestrand
Co-Investments: 1
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 1
AF
Europe, Aust-Agder, Norway, Arendal
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 4
Nysnø
Europe, Rogaland, Norway, Stavanger
Co-Investments: 1
Siemens Financial Services
Europe, Bayern, Germany, Munich
Co-Investments: 1
DP
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

What are some of recent deals done by PKA?

EnergyRe

New York, New York, United States

EnergyRe is at the center of the clean energy future.

Energy
Private EquityDec 4, 2023
Amount Raised: $1,200,000,000
Synklino

Lyngby, Hovedstaden, Denmark

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

BiotechnologyHealth Care
Series AJun 8, 2022
Amount Raised: $31,985,458
Morrow Batteries

Oslo, Oslo, Norway

Morrow Batteries is to develop and manufacture the world’s most cost-effective and sustainable battery cells.

BatteryElectrical DistributionElectronicsManufacturing
Series UnknownMay 22, 2022
Amount Raised: $105,705,005
Coexca

Talca, Maule, Chile

Coexca is a food processing startup that commercializes pork cuts in Asian markets, exporting to more than 20 countries.

Food and Beverage
Series UnknownMay 24, 2017
Amount Raised: $12,000,000
Symphogen

Lyngby, Hovedstaden, Denmark

Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.

BiopharmaBiotechnologyPharmaceutical
Debt FinancingOct 22, 2015
Amount Raised: $74,965,766
Symphogen

Lyngby, Hovedstaden, Denmark

Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.

BiopharmaBiotechnologyPharmaceutical
Private EquityMay 3, 2013
Amount Raised: $53,682,558
Symphogen

Lyngby, Hovedstaden, Denmark

Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.

BiopharmaBiotechnologyPharmaceutical
Series UnknownJan 6, 2011
Amount Raised: $130,285,181